The lung cancer field of cancerization has been intensively studied, starting from 1996 when Nelson et al. described the first mutations in the KRAS genes in nonmalignant adjacent tissue to lung cancer to further studies by Belinsky and colleagues. The gene discussed is KRAS; the disease is lung carcinoma.